Related Experiment Video
Updated: Feb 22, 2026
Fully Human Tumor-based Matrix in Three-dimensional Spheroid Invasion Assay
Published on: May 7, 2019
A versatile 3D tissue matrix scaffold system for tumor modeling and drug screening
1Department of Biomedical Sciences, Elson S. Floyd College of Medicine, Washington State University, Spokane, WA 99210, USA.
Abstract:
Most of the anticancer drug candidates entering preclinical trials fail to be approved for clinical applications. The following are among the main causes of these failures: studying molecular mechanisms of cancer development, identifying therapeutic targets, and testing drug candidates using inappropriate tissue culture models, which do not recapitulate the native microenvironment where the cancer cells originate. It has become clear that three-dimensional (3D) cell cultures are more biologically and clinically relevant than 2D models. The spatial and mechanical conditions of 3D cultures enable the cancer cells to display heterogeneous growth, assume diverse phenotypes, express distinct gene and protein products, and attain metastatic potential and resistance to drugs that are reminiscent of tumors in humans. However, the current 3D culture systems using synthetic polymers or selected components of the extracellular matrix (ECM) are defective (particularly the biophysical and biochemical properties of the native ECM) and remain distant to optimally support the signaling cue-oriented cell survival and growth. We introduce a reconstitutable tissue matrix scaffold (TMS) system fabricated using native tissue ECM, with tissue-like architecture and resilience. The structural and compositional properties of TMS favor robust cell survival, proliferation, migration, and invasion in culture and vascularized tumor formation in animals. The combination of porous and hydrogel TMS allows compartmental culture of cancerous and stromal cells, which are distinguishable by biomarkers. The response of the cancer cells grown on TMS to drugs well reflects animal and clinical observations. TMS enables more biologically relevant studies and is suitable for preclinical drug screening.
Insights
Developing novel tissue matrix scaffolds (TMS) using native extracellular matrix (ECM) improves preclinical cancer drug screening. This 3D model better mimics the tumor microenvironment, enhancing drug response prediction for clinical applications.
Area of Science:
- Biotechnology
- Cancer Research
- Biomaterials
Background:
- Most anticancer drug candidates fail in preclinical trials due to inadequate models.
- Current 3D cell cultures lack native extracellular matrix (ECM) properties, limiting biological relevance.
- Existing models do not fully recapitulate the tumor microenvironment's complexity.
Purpose of the Study:
- To develop a novel tissue matrix scaffold (TMS) system using native ECM.
- To create a 3D culture model that better mimics the in vivo tumor microenvironment.
- To improve the accuracy of preclinical cancer drug screening.
Main Methods:
- Fabrication of a reconstitutable tissue matrix scaffold (TMS) system from native tissue ECM.
- Utilizing a combination of porous and hydrogel TMS for compartmental cell culture.
- Assessing cell behavior (survival, proliferation, migration, invasion) and drug response in vitro.
- Evaluating tumor formation and vascularization in vivo.
Main Results:
- The TMS system demonstrated tissue-like architecture and resilience.
- TMS supported robust cell survival, proliferation, migration, and invasion.
- The model facilitated compartmental culture of cancer and stromal cells.
- Drug response in TMS cultures closely reflected animal and clinical observations.
- TMS enabled vascularized tumor formation in vivo.
Conclusions:
- The native ECM-based TMS system provides a more biologically relevant 3D model for cancer research.
- TMS enhances the predictive accuracy of preclinical drug screening.
- This advanced scaffold system is suitable for studying cancer biology and testing therapeutic agents.
